Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7716388

Concept 2018-03-01 to
2018-11-30
2017-03-01 to
2017-11-30
Consolidated statement of income
Statement of income
Net sales
102,574,000,000 JPY
109,553,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
124,000,000 JPY
JPY
Cost of sales
38,175,000,000 JPY
40,267,000,000 JPY
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
280,000,000 JPY
Operating expenses
Selling, general and administrative expenses
48,458,000,000 JPY
48,598,000,000 JPY
Operating expenses
Gross profit (loss)
64,399,000,000 JPY
69,285,000,000 JPY
Operating profit (loss)
15,941,000,000 JPY
20,687,000,000 JPY
Net sales
Ordinary profit (loss)
17,412,000,000 JPY
22,043,000,000 JPY
Extraordinary income
218,000,000 JPY
487,000,000 JPY
Gain on disposal of non-current assets
0 JPY
0 JPY
Non-operating income
1,499,000,000 JPY
1,718,000,000 JPY
Dividend income
535,000,000 JPY
501,000,000 JPY
Interest income
467,000,000 JPY
302,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Other
284,000,000 JPY
328,000,000 JPY
Extraordinary losses
9,000,000 JPY
6,000,000 JPY
Loss on disposal of non-current assets
9,000,000 JPY
6,000,000 JPY
Non-operating expenses
Interest expenses
16,000,000 JPY
25,000,000 JPY
Other
11,000,000 JPY
19,000,000 JPY
Non-operating expenses
28,000,000 JPY
361,000,000 JPY
Profit (loss) before income taxes
17,621,000,000 JPY
22,524,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
218,000,000 JPY
487,000,000 JPY
Extraordinary losses
Income taxes
4,113,000,000 JPY
6,478,000,000 JPY
Profit (loss)
13,507,000,000 JPY
16,046,000,000 JPY
Profit (loss) attributable to non-controlling interests
178,000,000 JPY
206,000,000 JPY
Profit (loss) attributable to owners of parent
13,329,000,000 JPY
15,840,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
1,239,000,000 JPY
4,873,000,000 JPY
Foreign currency translation adjustment
-33,000,000 JPY
-1,876,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-60,000,000 JPY
44,000,000 JPY
Remeasurements of defined benefit plans, net of tax
168,000,000 JPY
197,000,000 JPY
Other comprehensive income
1,313,000,000 JPY
3,239,000,000 JPY
Comprehensive income
14,821,000,000 JPY
19,286,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
14,682,000,000 JPY
19,098,000,000 JPY
Comprehensive income attributable to non-controlling interests
138,000,000 JPY
187,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.